Sign In
Buy BNTX
$88.45
-0.690 (-0.774%)
At Close: Jun 03, 2026
Why Moderna, BioNTech SE, and Novavax Surged Today
04:50pm, Monday, 21'st Aug 2023
Last week, Moderna and BioNTech partner Pfizer said their new COVID vaccines work against the current dominant strain of omicron growing across the U.S. Today, the Biden administration announced a cam
Covid vaccine stocks jump as new variants emerge ahead of fall shot rollout
12:44pm, Monday, 21'st Aug 2023
Novavax, Moderna, Pfizer and its partner BioNTech are slated to roll out new shots designed to target the omicron subvariant XBB.1.5 this fall.
The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023
05:12am, Thursday, 17'th Aug 2023
The events of the last few years have made biotech investing look easier than it is. But, investing in biotech is not for the faint of heart.
Why BioNTech Stock Was Sinking Today
03:46pm, Monday, 07'th Aug 2023
The company fell far short of analyst revenue estimates in its latest-reported quarter. It also flipped to a loss on the bottom line.
BioNTech SE (BNTX) Q2 2023 Earnings Call Transcript
01:23pm, Monday, 07'th Aug 2023
BioNTech SE (NASDAQ:BNTX ) Q2 2023 Earnings Conference Call August 7, 2023 8:00 AM ET Company Participants Victoria Meissner - VP, Strategy & IR Ugur Sahin - Co-Founder & CFO Ozlem Tureci - Chief Medi
BioNTech Revenue Plunges on Falling Demand for COVID-19 Vaccines
01:15pm, Monday, 07'th Aug 2023
American Depositary Receipts of BioNTech sank as COVID-19 vaccine demand waned and sales of its vaccine plunged.
Biotech Stock Hits 2-Year Low as Vaccine Sales Decline
11:05am, Monday, 07'th Aug 2023
BioNTech SE (NASDAQ:BNTX) is sinking to two-year lows today, after plunging Covid vaccine sales weighed on the company's second-quarter results.
BioNTech stock declines as revenue topples on lower demand for Covid vaccine
07:36am, Monday, 07'th Aug 2023
BioNTech has reported a sharp decline in second-quarter revenue and swung to a loss as demand for COVID-19 vaccines fell, sending its shares lower in Monday pre-market trading on the Nasdaq. The Germa
BioNTech Stock Falls. The Covid-19 Vaccine Maker Misses Revenue Estimates.
06:50am, Monday, 07'th Aug 2023
Sales drop by more than expected in the second quarter, but BioNTech says its new 'variant-adapted Covid-19 vaccine' is still on track.
BioNTech reduces drug development spend as COVID vaccine sales plunge
06:19am, Monday, 07'th Aug 2023
Germany's BioNTech , Pfizer's partner on COVID-19 vaccines, cut its drug development budget for this year after quarterly revenues were hurt by a plunge in pandemic-related demand.
BioNTech stock drops after revenue falls well short of expectations, but affirms 2023 COVID vaccine revenue view
06:17am, Monday, 07'th Aug 2023
Shares of BioNTech SE BNTX, -0.16% dropped 2.4% toward a three-month low in premarket trading Monday, after the Germany-based biotechnology company, which developed a COVID-19 vaccine with partner Pfi
Disney, UPS, and More Stocks to Watch This Week
02:00pm, Sunday, 06'th Aug 2023
Earnings season rolls along this week, with reports also due from Paramount, Eli Lilly, Wynn Resorts, and many more. And look out for crucial inflation indicators in economic data to be released at we
BioNTech: Unraveling A Bargain, A Hidden Opportunity In Market Misjudgments
03:27am, Friday, 04'th Aug 2023
A leading immunotherapy innovator with a focus on oncology and infectious diseases. With a strong pipeline and capable management, the company is likely to continue its success in the long run. A proj
BioNTech to Report Second Quarter 2023 Financial Results and Operational Update on August 7, 2023
06:45am, Monday, 24'th Jul 2023
MAINZ, Germany , July 24, 2023 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the second quarter 2023 on Monday, August 7t
Why These 7 Stocks Are the Best Ways to Play Biotech Right Now
08:53pm, Tuesday, 11'th Jul 2023
Best biotech stocks represents a concept that, no matter what, the market cycle fundamentally delivers relevance. Now, let me back up by stating that no individual company offers a guarantee of succes
